Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

By GINA KOLATA from NYT Health https://ift.tt/2CQNI7l
via IFTTT
Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.
Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? - By GINA KOLATA - at Health - Keyword: Transplants, Drugs (Pharmaceuticals) - From The New York Times - Published at April 2, 2019 at 07:00AM